logo
Tamboran Finalizes the Checkerboard of Beetaloo Basin Blocks and Announces US$15 Million Acreage Sale to Daly Waters Energy, LP

Tamboran Finalizes the Checkerboard of Beetaloo Basin Blocks and Announces US$15 Million Acreage Sale to Daly Waters Energy, LP

Yahoo13-05-2025

Highlights
Tamboran and Daly Waters Energy, LP (DWE) have signed a binding agreement to finalize the checkerboard of the joint acreage position across EPs 76, 98 and 117.
In conjunction with the checkerboard, Tamboran and DWE have entered into a binding agreement whereby DWE will acquire a non-operating and non-controlling interest in 100,000 acres within two areas for a consideration of US$15 million. The transaction is subject to certain conditions precedent and regulatory approvals.
On completion, Tamboran will have retained approximately 1.9 million net prospective, development-ready acres across the Beetaloo Basin.
Tamboran has reserved 406,693 gross acres as its Phase 2 Development Area, located immediately north of the Pilot Area, where Tamboran plans to focus development on supplying gas into Australia's East Coast domestic gas market.
On completion of the sale to DWE, Tamboran is expected to hold 236,370 net acres (58.12% operated interest) over the Phase 2 Development Area, with DWE (19.38%) and Falcon Oil & Gas Australia Limited (Falcon) (22.5%) holding the remaining interest.
Tamboran has engaged RBC Capital Markets to commence a formal farm-down of the Phase 2 Development Area. The formal process will commence on release of the IP30 flow test from the Shenandoah South 2H sidetrack (SS-2H ST1) well, planned for June 2025. DWE will have participation rights to any transaction on the same terms.
Ownership of the proposed northern Pilot Area, which will provide initial gas production to the Northern Territory, remains unchanged (Tamboran 47.5% operator) with expansion into the proposed southern Pilot Area (Tamboran 38.75%) anticipated in accordance with the terms of the acreage sale. Future working interests are subject to participation of parties in the Joint Venture.
Tamboran will hold 77.5% operating interest in the remaining half of the ex-EP 76, 98 and 117 acreage positions following the completion of the checkboard process, with Falcon holding the remaining 22.5% interest.
NEW YORK, May 13, 2025--(BUSINESS WIRE)--Tamboran Resources Corporation (NYSE: TBN, ASX: TBN):
Tamboran Resources Corporation Chief Executive Officer, Joel Riddle, said:
"We have engaged RBC Capital Markets to progress a farm down of acreage to carry Tamboran through the delineation of gas resources to underpin our Phase 2 strategy.
"Tamboran and DWE will continue working together on the Pilot Area, where we are focused on the development of the proposed 40 MMcf/d Shenandoah South Pilot Project. Tamboran's recently secured funding is expected to support the drilling activities required to reach initial production in mid-2026, subject to weather and customary regulatory approvals.
"DWE will also participate in our Phase 2 Development Area and we look forward to continuing to work with DWE on progressing our joint ambition to be a major gas supplier to the East Coast gas market at a time when the market is anticipating a shortfall at the back end of the decade."
Checkerboard update
Tamboran and DWE (100% owned by Formentera Australia Fund, LP) have signed a binding agreement to finalize the checkerboard of the joint acreage position across EPs 76, 98 and 117.
Under the process, Tamboran and DWE selected acreage, resulting in each party holding regions at a 77.5% owned and operated working interest (Falcon hold the remaining 22.5% non-operating interest).
Ownership of the proposed northern Pilot Area, the focus for initial gas production in the Northern Territory, remains unchanged (Tamboran 47.5% operator, DWE 47.5% and Falcon 5%) with expansion into the southern Pilot Area (Tamboran 38.75%, DWE 38.75% operator and Falcon 22.5%) anticipated in accordance with the terms of the acreage sale.
Acreage sale
In conjunction with the checkerboard, Tamboran and DWE have entered into a binding agreement whereby DWE will acquire a non-operating and non-controlling interest across 100,000 acres within two areas of Tamboran's post-checkerboard acreage position for a consideration of US$15 million.
The transaction is subject to certain conditions precedent including, and not limited to, DWE obtaining approval from the Formentera Australia Fund, LP's Limited Partner Advisory Committee, Tamboran shareholder approval and regulatory approvals.
Farm down update
Tamboran has engaged RBC Capital Markets to conduct a farm down process of the area designated as Phase 2 Development Area. This area covers 406,693 acres located immediately north of the Pilot Area.
The process is expected to commence following results of the SS-2H ST1 well, which is planned to be released in June 2025.
DWE will have the right to participate in any farm down deal at the same terms provided to Tamboran.
Figure 2: Tamboran net prospective acres across the Beetaloo Basin assets
Company
Gross Acreage
Interest
Net Acreage
Proposed northern Pilot Project Area1
20,309
47.50%
9,647
Proposed southern Pilot Project Area
20,309
38.75%
7,870
Phase 2 Development Area
406,693
58.12%
236,370
Proposed Retention Lease 10
219,030
67.83%
148,568
Remaining ex-EP 76, 98 and 117 acreage
1,487,418
77.50%
1,152,749
EP 136
207,000
100.00%
207,000
EP 161
512,000
25.00%
128,000
Total
2,872,759
1,890,204
May not add due to rounding.1Subject to the completion of the SS-2H ST1 and SS-3H wells on the Shenandoah South pad 2.
Working Interests – Phase 2 Development Area
Company
Previous
New
Tamboran (West) Pty Limited1
38.75%
58.12%
Daly Waters Energy, LP
38.75%
19.38%
Falcon Oil and Gas Australia Limited
22.50%
22.50%
Total
100.0%
100.0%
Working Interests – Proposed RL10
Company
Previous
New
Tamboran (West) Pty Limited1
38.75%
67.83%
Daly Waters Energy, LP
38.75%
9.67%
Falcon Oil and Gas Australia Limited
22.5%
22.50%
Total
100.0%
100.0%
Working Interests – Remaining Tamboran owned Ex-EP 76, 98 and 117 acreage
Company
Previous
New
Tamboran (West) Pty Limited1
38.75%
77.5%
Daly Waters Energy, LP
38.75%
-
Falcon Oil and Gas Australia Limited
22.5%
22.5%
Total
100.0%
100.0%
1Denotes operatorship of the assets.
This announcement was approved and authorized for release by Joel Riddle, Chief Executive Officer of Tamboran Resources Corporation.
About Tamboran Resources Corporation
Tamboran Resources Corporation ("Tamboran" or the "Company"), through its subsidiaries, is the largest acreage holder and operator with approximately 1.9 million net prospective acres in the Beetaloo Sub-basin within the Greater McArthur Basin in the Northern Territory of Australia.
Tamboran's key assets include a 47.5% operating interest over 20,309 acres in the proposed northern Pilot Area, a 38.75% non-operating interest over 20,309 acres in the proposed southern Pilot Area, a 58.13% operating interest in the proposed Phase 2 development area covering 406,693 acres, a 67.83% operated interest over 219,030 acres in a proposed Retention License 10, a 77.5% operating interest across 1,487,418 acres over ex-EPs 76, 98 and 117, a 100% working interest and operatorship in EP 136 and a 25% non-operated working interest in EP 161, which are all located in the Beetaloo Basin.
The Company has also secured ~420 acres (170 hectares) of land at the Middle Arm Sustainable Development Precinct in Darwin, the location of Tamboran's proposed NTLNG project. Pre-FEED activities are being undertaken by Bechtel Corporation.
Disclaimer
Tamboran makes no representation, assurance or guarantee as to the accuracy or likelihood of fulfilment of any forward-looking statement or any outcomes expressed or implied in any forward-looking statement. The forward-looking statements in this report reflect expectations held at the date of this document. Except as required by applicable law or the ASX Listing Rules, Tamboran disclaims any obligation or undertaking to publicly update any forward-looking statements, or discussion of future financial prospects, whether as a result of new information or of future events.
The information contained in this announcement does not take into account the investment objectives, financial situation or particular needs of any recipient and is not financial product advice. Before making an investment decision, recipients of this announcement should consider their own needs and situation and, if necessary, seek independent professional advice. To the maximum extent permitted by law, Tamboran and its officers, employees, agents and advisers give no warranty, representation or guarantee as to the accuracy, completeness or reliability of the information contained in this presentation. Further, none of Tamboran nor its officers, employees, agents or advisers accept, to the extent permitted by law, responsibility for any loss, claim, damages, costs or expenses arising out of, or in connection with, the information contained in this announcement.
Note on Forward-Looking Statements
This press release contains "forward-looking" statements related to the Company within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and Section 27A of the Securities Act of 1933, as amended. Forward-looking statements reflect the Company's current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words "believe," "expect," "anticipate," "will," "could," "would," "should," "may," "plan," "estimate," "intend," "predict," "potential," "continue," "participate," "progress," "conduct" and the negatives of these words and other similar expressions generally identify forward-looking statements.
It is possible that the Company's future financial performance may differ from expectations due to a variety of factors, including but not limited to: our early stage of development with no material revenue expected until 2026 and our limited operating history; the substantial additional capital required for our business plan, which we may be unable to raise on acceptable terms; our strategy to deliver natural gas to the Australian East Coast and select Asian markets being contingent upon constructing additional pipeline capacity, which may not be secured; the absence of proved reserves and the risk that our drilling may not yield natural gas in commercial quantities or quality; the speculative nature of drilling activities, which involve significant costs and may not result in discoveries or additions to our future production or reserves; the challenges associated with importing U.S. practices and technology to the Northern Territory, which could affect our operations and growth due to limited local experience; the critical need for timely access to appropriate equipment and infrastructure, which may impact our market access and business plan execution; the operational complexities and inherent risks of drilling, completions, workover, and hydraulic fracturing operations that could adversely affect our business; the volatility of natural gas prices and its potential adverse effect on our financial condition and operations; the risks of construction delays, cost overruns, and negative effects on our financial and operational performance associated with midstream projects; the potential fundamental impact on our business if our assessments of the Beetaloo are materially inaccurate; the concentration of all our assets and operations in the Beetaloo, making us susceptible to region-specific risks; the substantial doubt raised by our recurring operational losses, negative cash flows, and cumulative net losses about our ability to continue as a going concern; complex laws and regulations that could affect our operational costs and feasibility or lead to significant liabilities; community opposition that could result in costly delays and impede our ability to obtain necessary government approvals; exploration and development activities in the Beetaloo that may lead to legal disputes, operational disruptions, and reputational damage due to native title and heritage issues; the requirement to produce natural gas on a Scope 1 net zero basis upon commencement of commercial production, with internal goals for operational net zero, which may increase our production costs; the increased attention to ESG matters and environmental conservation measures that could adversely impact our business operations; risks related to our corporate structure; risks related to our common stock and CDIs; and the other risk factors discussed in the this report and the Company's filings with the Securities and Exchange Commission.
It is not possible to foresee or identify all such factors. Any forward-looking statements in this document are based on certain assumptions and analyses made by the Company in light of its experience and perception of historical trends, current conditions, expected future developments, and other factors it believes are appropriate in the circumstances. Forward-looking statements are not a guarantee of future performance and actual results or developments may differ materially from expectations. While the Company continually reviews trends and uncertainties affecting the Company's results of operations and financial condition, the Company does not assume any obligation to update or supplement any particular forward-looking statements contained in this document.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250513389494/en/
Contacts
Investor enquiries: Chris Morbey, Vice President – Corporate Development and Investor Relations+61 2 8330 6626Investors@tamboran.com
Media enquiries: +61 2 8330 6626Media@tamboran.com

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Shareholder Alert: The Ademi Firm Investigates Whether Sitio Royalties Corp. Is Obtaining a Fair Price for Its Public Shareholders
Shareholder Alert: The Ademi Firm Investigates Whether Sitio Royalties Corp. Is Obtaining a Fair Price for Its Public Shareholders

Associated Press

time19 minutes ago

  • Associated Press

Shareholder Alert: The Ademi Firm Investigates Whether Sitio Royalties Corp. Is Obtaining a Fair Price for Its Public Shareholders

MILWAUKEE--(BUSINESS WIRE)--Jun 3, 2025-- The Ademi Firm is investigating Sitio (NYSE: STR) for possible breaches of fiduciary duty and other violations of law in its transaction with Viper Energy . Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, shareholders of Sitio will receive 0.4855 shares of Class A common stock of a new holding company ('pro forma Viper') for each share of Sitio Class A common stock, and 0.4855 units of Viper's operating subsidiary, Viper Energy Partners LLC, for each unit of Sitio's operating subsidiary (along with a corresponding amount of Class B common stock of pro forma Viper for each share of Sitio Class C common stock), representing an implied value to each Sitio stockholder of $19.41 per share based on the closing price of Viper common stock on June 2, 2025. Sitio insiders will receive substantial benefits as part of change of control arrangements. The transaction agreement unreasonably limits competing transactions for Sitio by imposing a significant penalty if Sitio accepts a competing bid. We are investigating the conduct of the Sitio board of directors, and whether they are fulfilling their fiduciary duties to all shareholders. We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes. View source version on CONTACT: Ademi & Fruchter LLP Guri Ademi Toll Free: (866) 264-3995 Fax: (414) 482-8001 KEYWORD: UNITED STATES NORTH AMERICA WISCONSIN INDUSTRY KEYWORD: CLASS ACTION LAWSUIT PROFESSIONAL SERVICES LEGAL SOURCE: Ademi & Fruchter LLP Copyright Business Wire 2025. PUB: 06/03/2025 07:41 AM/DISC: 06/03/2025 07:40 AM

AT&T to Webcast Fireside Chat with Pascal Desroches at the 2025 Mizuho Technology Conference on June 10
AT&T to Webcast Fireside Chat with Pascal Desroches at the 2025 Mizuho Technology Conference on June 10

Yahoo

time32 minutes ago

  • Yahoo

AT&T to Webcast Fireside Chat with Pascal Desroches at the 2025 Mizuho Technology Conference on June 10

DALLAS, June 3, 2025 /PRNewswire/ -- Tune in for a fireside chat with Pascal Desroches at the 2025 Mizuho Technology Conference scheduled to begin at 8:15 a.m. ET. Webcast available live and for replay. Key Takeaways: AT&T to webcast fireside chat with Pascal Desroches at the 2025 Mizuho Technology Conference. AT&T (NYSE:T) will webcast a fireside chat with Pascal Desroches, chief financial officer, AT&T Inc., at the Annual Mizuho Technology Conference on Tuesday, June 10, 2025. The conversation is scheduled to begin at 8:15 a.m. ET. To hear more, tune into the webcast live or listen to the replay on the AT&T Investor Relations website. Viewers should start the webcast a few minutes before the planned start time in case the conference schedule changes. To automatically receive AT&T financial news by email, please subscribe to email alerts. About AT&T We help more than 100 million U.S. families, friends and neighbors, plus nearly 2.5 million businesses, connect to greater possibility. From the first phone call 140+ years ago to our 5G wireless and multi-gig internet offerings today, we @ATT innovate to improve lives. For more information about AT&T Inc. (NYSE:T), please visit us at Investors can learn more at © 2025 AT&T Intellectual Property. All rights reserved. AT&T and the Globe logo are registered trademarks of AT&T Intellectual Property. View original content to download multimedia: SOURCE ATT

Asia-Pacific Pediatric Interventional Cardiology Industry Report 2025-2033: Insights Into Markets, Shares, Companies, Trends, Growth Opportunities and More
Asia-Pacific Pediatric Interventional Cardiology Industry Report 2025-2033: Insights Into Markets, Shares, Companies, Trends, Growth Opportunities and More

Yahoo

time33 minutes ago

  • Yahoo

Asia-Pacific Pediatric Interventional Cardiology Industry Report 2025-2033: Insights Into Markets, Shares, Companies, Trends, Growth Opportunities and More

Driving factors include rising congenital heart defect cases, healthcare advancements, governmental support, and demographic trends in China and India Dublin, June 03, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Pediatric Interventional Cardiology Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to offering. The Asia-Pacific Pediatric Interventional Cardiology Market is expected to reach US$ 1.52 billion by 2033 from US$ 829.09 million in 2024, with a CAGR of 7.01% from 2025 to 2033. Increased cases of congenital heart defects, improved healthcare infrastructure, increased public awareness, technological innovations, encouraging governmental support, and increasing child populations - especially in developing countries such as China and India - are all contributing to the Asia-Pacific pediatric interventional cardiology market. The specialty branch of pediatric interventional cardiology is committed to minimally invasive diagnosis and treatment of cardiac ailments in neonates, children, and adolescents. Interventional cardiologists perform procedures such as fixing congenital heart defects, opening narrowed valves or arteries, and closing septal defects with catheters inserted via blood vessels instead of open heart surgery. Typically, imaging devices such as echocardiography or fluoroscopy guide these operations. In comparison to surgery, the technique offers faster recovery, less time in the hospital, and fewer complications. To address congenital and acquired cardiac issues and improve the quality of life of young children, pediatric interventional cardiology is a must. Several key drivers are responsible for the significant growth of the Asia-Pacific pediatric interventional cardiology market. The demand for better pediatric cardiac care is fueled by the increasing prevalence of congenital heart diseases, particularly in populous countries such as China and India. Availability of minimally invasive interventions is being enhanced by improved healthcare infrastructure, increased government support, and increased investment in medical technology. In addition, the availability of skilled healthcare professionals, increased health insurance coverage, and improved parental awareness are all contributing to market growth. Adoption of pediatric interventional cardiology in the Asia-Pacific region is being led by advances in diagnostic equipment and interventional devices, which also facilitate enhanced outcomes. The Asia-Pacific Pediatric Interventional Cardiology Market is expected to grow enormously because of the rise in the number of congenital heart abnormalities (CHDs). The rate of babies born with congenital heart defects has increased enormously because of the rise in birth rates in countries like China and India. Due to advances in diagnostic technologies such as newborn screening and fetal echocardiography, early identification has increased. As parents and physicians become increasingly aware, more children are being diagnosed early and referred for treatment. Open cardiac surgery is less required when these issues are treated with minimally invasive methods offered by pediatric interventional cardiology. Advanced pediatric cardiac interventions remain in high demand in the Asia-Pacific region because of the increasing incidence of congenital heart disease and greater access to specialist care. The Asia-Pacific Pediatric Interventional Cardiology Market is likely to grow tremendously with the enhanced healthcare infrastructure. In countries such as China, India, and Southeast Asia, economic growth and urbanization have led to massive investments in healthcare systems. Availability of quality interventional therapy to children with heart issues has been enhanced through the expansion of specialist cardiac centers, the presence of state-of-the-art medical technology, and improved training of pediatric cardiologists. Treatment outcomes and hospital capacities are being enhanced through international cooperation and public-private alliances. Demand is also being driven by the expansion of digital health platforms and telemedicine, which are bridging the gap between rural communities and specialist cardiac care. In Asia-Pacific, increasing numbers of children are enjoying early diagnosis and minimally invasive cardiac surgery as healthcare systems improve. Asia-Pacific Pediatric Interventional Cardiology Market is anticipated to grow enormously due to technological advances in minimally invasive technology. Pediatric cardiac therapy has been revolutionized by leaps in imaging modalities, catheter-based intervention, and downsized devices. Congenital heart disease now can be targeted exactly and effectively with no need for open-heart surgery due to these technologies that reduce hospital stay, accelerate recovery, and reduce risk of complications. The development of smaller, child-specific devices such as balloons, stents, and occluders has enhanced the safety and effectiveness of newborn and young children's treatments. With growing investments in healthcare innovation, countries in the Asia-Pacific region are adopting these advanced tools at a growing pace. Treatment options and market expansion are being significantly enhanced by the incorporation of technology in pediatric cardiology as it becomes increasingly accessible and affordable. One major obstacle facing the Asia-Pacific pediatric interventional cardiology market is the high cost of therapy. Many families, especially those in lower-income areas, cannot afford the high costs of advanced operations, specialist equipment, and hospital stays. Even though insurance coverage is growing, it frequently falls short of covering all expenses, particularly in developing nations. The overall development and efficacy of pediatric interventional cardiology in the area are hampered by this financial barrier, which restricts children with congenital heart abnormalities' access to prompt, life-saving therapies. The Asia-Pacific Pediatric Interventional Cardiology Market faces many challenges, one of which is limited access to specialized care. Advanced pediatric cardiac centers are few and far between, and healthcare infrastructure is sometimes inadequate in rural and isolated places. Timely identification and treatment of congenital cardiac abnormalities are hindered by this lack of access. Long commutes to receive care may be necessary for families in underprivileged areas, further postponing intervention. This discrepancy in access to healthcare poses serious obstacles to fair treatment throughout the area. Key Attributes Report Attribute Details No. of Pages 200 Forecast Period 2024-2033 Estimated Market Value (USD) in 2024 $829.09 Million Forecasted Market Value (USD) by 2033 $1.52 Billion Compound Annual Growth Rate 7% Regions Covered Asia-Pacific Key Topics Covered1. Introduction2. Research & Methodology2.1 Data Source2.1.1 Primary Sources2.1.2 Secondary Sources2.2 Research Approach2.2.1 Top-Down Approach2.2.2 Bottom-Up Approach2.3 Forecast Projection Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Asia-Pacific Pediatric Interventional Cardiology Market5.1 Historical Market Trends5.2 Market Forecast6. Asia-Pacific Pediatric Interventional Cardiology Market Share Analysis6.1 By Device Type6.2 By Procedure6.3 By End Use6.4 By Countries7. Device Type7.1 Transcatheter Heart Valves7.2 Atherectomy Devices7.3 Catheters7.4 Closure Devices7.5 Balloons7.6 Stents7.7 Others8. Procedure8.1 Catheter-based Valve Implantation8.2 Congenital Haert Defect Correction8.3 Angioplasty8.4 Coronary Thrombectomy8.5 Others9. End Use9.1 Hospitals9.2 Ambulatory Surgical Centers9.3 Others10. Countries10.1 China10.2 Japan10.3 India10.4 South Korea10.5 Thailand10.6 Malaysia10.7 Indonesia10.8 Australia10.9 New Zealand10.10 Rest of Asia-Pacific11. Porter's Five Forces Analysis11.1 Bargaining Power of Buyers11.2 Bargaining Power of Suppliers11.3 Degree of Rivalry11.4 Threat of New Entrants11.5 Threat of Substitutes12. SWOT Analysis12.1 Strength12.2 Weakness12.3 Opportunity12.4 Threat13. Key Players Analysis13.1 Abbott Laboratories Inc.13.1.1 Overviews13.1.2 Key Person13.1.3 Recent Developments & Strategies13.1.4 Revenue Analysis13.2 Boston Scientific Corporation13.3 Medtronic PLC13.4 B. Braun13.5 Biosensors International Group, Ltd.13.6 Siemens AG13.7 Cardinal Health Inc.13.8 Terumo Medical CorporationFor more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store